Antibacterial therapy for severe sarcoid uveitis

Phase 1

• Conditions: Severe uveitis by sarcoidosis; Other eyes and adnexal disease

• Registration Number: JPRN-jRCTs031180301
• Lead Sponsor: Takase Hiroshi

Brief Summary

Because appropriate patient could not be recruited, this study was terminated on October 28, 2020.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-15
• Study Completion: 2020-10-28
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 0

Inclusion Criteria

Active uveitis by sarcoidosis at vitreous body or fundus

Exclusion Criteria

Systemic infectious disease

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Disappearance of symptom

Secondary Outcome Measures

Name	Time	Method
Occurrence of adverse events